New cancer drug injected directly into tumors shows early promise
NCT ID NCT05549804
First seen Nov 18, 2025 · Last updated Jun 14, 2026 · Updated 22 times
Summary
This early-stage study tested a new drug called KL340399 in 6 people with advanced solid tumors that had not responded to standard treatments. The drug was injected directly into the tumor to see if it was safe and what dose might work best. The main goal was to find the highest safe dose and check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.